ARVN Insider Trading Activity and SEC Form 4 Filings
ARVN insider trading summary
Over the past 12 months, insiders at Arvinas, Inc. (ARVN) reported 22 sales worth $1.3M by 6 insiders and 1 open-market purchase worth $268K by 1 insider on SEC Form 4. Net insider selling was $1.1M.
Latest ARVN insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 24, 2026 | Andrew Saik | Chief Financial Officer | Sell | $46K (5,696 @ $8.16) |
| Jun 17, 2026 | Angela M Cacace | Chief Scientific Officer | Sell | $20K (2,576 @ $7.59) |
| May 21, 2026 | Randy Teel | President and CEO | Sell | $20K (2,209 @ $9.04) |
| May 11, 2026 | Andrew Saik | Chief Financial Officer | Sell | $111K (11,139 @ $9.94) |
| May 11, 2026 | David K Loomis | VP, Chief Accounting Officer | Sell | $19K (1,919 @ $9.94) |
| May 11, 2026 | Angela M Cacace | Chief Scientific Officer | Sell | $96K (9,657 @ $9.94) |
| May 11, 2026 | Noah Berkowitz | Chief Medical Officer | Sell | $110K (11,108 @ $9.94) |
| May 11, 2026 | Randy Teel | President and CEO | Sell | $96K (9,657 @ $9.94) |
| Mar 6, 2026 | Briggs Morrison | Director | Buy | $268K (20,000 @ $13.40) |
| Feb 27, 2026 | John G Houston | Director | Sell | $249K (18,822 @ $13.24) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.